HCAT peer analysis
Health Catalyst (HCAT) against its competitors: price, today's move, 1-year return and market value side by side.
- HCAT's peers: CRBU (Caribou Biosciences), ENTA (Enanta Pharmaceuticals), HSDT (Solana), NNOX (Nano-X Imaging), OBIO (Orchestra BioMed), OM (Outset Medical), PRLD (Prelude Therapeutics Incorporated), PYXS (Pyxis Oncology).
HCAT and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| CRBU Caribou Biosciences | $0.30 | -4.86% | -83.77% | $31.91M |
| ENTA Enanta Pharmaceuticals | $7.62 | -4.51% | -37.18% | $221.94M |
| HSDT Solana | $1.66 | 1.84% | -55.85% | $104.39M |
| NNOX Nano-X Imaging | $0.23 | 1.00% | -92.33% | $18.30M |
| OBIO Orchestra BioMed | $6.58 | -6.00% | 41.20% | $517.88M |
| OM Outset Medical | $2.91 | -4.28% | -36.32% | $54.86M |
| PRLD Prelude Therapeutics Incorporated | $3.22 | -1.08% | 92.81% | $257.83M |
| PYXS Pyxis Oncology | $1.81 | 7.74% | -60.39% | $216.49M |
| SNWV SANUWAVE Health | $1.59 | -7.02% | -95.05% | $13.68M |
| TNYA Tenaya Therapeutics | $0.29 | -1.54% | -75.30% | $66.99M |
| HCAT Health Catalyst | $1.29 | 0.00% | -38.86% | $98.24M |